Apriori is creating a world that is protected against viral threats. Its pioneering approach centres on a unique biology-informed artificial intelligence (AI) platform, Octavia, which can survey the landscape of existing and potential viral variants to design new vaccines and antibody drugs against the most threatening variants. Octavia can also generate real-time, actionable insights into emerging pathogens to inform public health decisions and policies.